ESAB Corp (ESAB) stock

ESABNYSEGeneral Industrial Machinery & Equipment, NECFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Nov 4, 2026Score 7/306% above fair value

$83.25+0.70 (+0.85%)

Close on Nov 13, 2026Market cap $5.18BP/E 28.9Yield 0.46%

Earnings

ESAB's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 19, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$825.00M

+13.3% on a year earlier

core adjusted diluted earnings per share, Q3 FY2026

$1.30

$1.32 a year earlier

Latest guidance

Raised

Nov 4, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of ESAB's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 19, 2027Expected	–	–	–	–	–
Q3 FY2026ended Oct 2, 2026	Nov 4, 2026before the open	$825.00M	+13.3%	$0.61	$1.30	Release
Q2 FY2026ended Jul 3, 2026	Aug 6, 2026before the open	$808.00M	+12.8%	$0.54	$1.33	Release
Q1 FY2026ended Apr 3, 2026	May 7, 2026before the open	$746.00M	+10.0%	$0.82	$1.31	Release
Q4 FY2025ended Dec 31, 2025	Feb 20, 2026before the open	$721.00M	+7.5%	$0.82	$1.35	Release
Q3 FY2025ended Oct 3, 2025	Oct 29, 2025before the open	$728.00M	+8.2%	$1.04	$1.32	Release
Q2 FY2025ended Jul 4, 2025	Aug 6, 2025before the open	$716.00M	+1.3%	$1.12	$1.36	Release
Q1 FY2025ended Apr 4, 2025	May 1, 2025before the open	$678.00M	-1.7%	$1.14	$1.25	Release
Q4 FY2024ended Dec 31, 2024	Feb 20, 2025before the open	$671.00M	-2.6%	$1.18	$1.28	Release
Q3 FY2024ended Sep 27, 2024	Oct 29, 2024before the open	$673.00M	-1.2%	$1.13	$1.25	Release
Q2 FY2024ended Jun 28, 2024	Aug 2, 2024before the open	$707.00M	-1.8%	$1.37	$1.32	Release
Q1 FY2024ended Mar 29, 2024	May 1, 2024before the open	$690.00M	+0.9%	$1.00	$1.20	Release
Q4 FY2023ended Dec 31, 2023	Feb 29, 2024before the open	$689.00M	+3.8%	$0.96	$1.13	Release
Q3 FY2023ended Sep 29, 2023	Nov 1, 2023before the open	$681.00M	+9.8%	$0.97	$1.08	Release
Q2 FY2023ended Jun 30, 2023	Aug 1, 2023before the open	$720.00M	+8.9%	$1.10	$1.21	Release
Q1 FY2023ended Mar 31, 2023	May 2, 2023before the open	$684.00M	+5.6%	$0.54	$1.04	Release
Q4 FY2022ended Dec 31, 2022	Mar 7, 2023before the open	$664.00M	–	$0.97	$1.05	Release
Q3 FY2022ended Sep 30, 2022	Nov 3, 2022before the open	$620.00M	–	$0.88	$0.92	Release
Q2 FY2022ended Jul 1, 2022	Aug 9, 2022before the open	$661.20M	–	$0.94	$1.14	Release
Q1 FY2022ended Apr 1, 2022	May 10, 2022before the open	$647.90M	–	$0.96	$1.17	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

ESAB's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Core revenuenon-GAAP	FY2026	$2.85B – $2.95B	–	New	Feb 2, 2026
total core sales growthnon-GAAP	FY2026	+13.1% – +13.3%	+6% – +9%	Raised	Nov 4, 2026
total core sales growthnon-GAAP	FY2026	+11% – +14%	+6% – +9%	Raised	Aug 6, 2026
core organic salesnon-GAAP	FY2026	+2% – +4%	+2% – +4%	Reaffirmed	Aug 6, 2026
core adjusted EBITDAnon-GAAP	FY2026	$603.00M – $607.00M	$575.00M – $595.00M	Raised	Nov 4, 2026
core adjusted EBITDAnon-GAAP	FY2026	$615.00M – $625.00M	$575.00M – $595.00M	Raised	Aug 6, 2026
core adjusted EPSnon-GAAP	FY2026	$5.28 – $5.33	$5.70 – $5.90	Lowered	Nov 4, 2026
core adjusted EPSnon-GAAP	FY2026	$5.40 – $5.50	$5.70 – $5.90	Lowered	Aug 6, 2026
anticipated FX impact	FY2026	0% – +1%	–	Lowered	Aug 6, 2026
contribution from M&A	FY2026	+9%	–	Raised	Aug 6, 2026
FX impact	FY2026	0% – +1%	–	Lowered	May 7, 2026
M&A contribution	FY2026	+4%	–	New	May 7, 2026

Guidance vs results

The last range ESAB gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	core adjusted EPS	$5.20 – $5.30	$5.28Σ4Q	Within range
FY2025	Revenue growth	+4.5% – +5.5%	+3.72%Σ4Q	Below range

Guidance history

Every forecast ESAB put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 4, 2026	core adjusted EBITDA	FY2026	$603.00M – $607.00M	Raised
Nov 4, 2026	core adjusted EPS	FY2026	$5.28 – $5.33	Lowered
Nov 4, 2026	total core sales growth	FY2026	+13.1% – +13.3%	Raised
Aug 6, 2026	core organic sales	FY2026	+2% – +4%	Reaffirmed
Aug 6, 2026	core adjusted EBITDA	FY2026	$615.00M – $625.00M	Raised
Aug 6, 2026	core adjusted EPS	FY2026	$5.40 – $5.50	Lowered
Aug 6, 2026	contribution from M&A	FY2026	+9%	Raised
Aug 6, 2026	anticipated FX impact	FY2026	0% – +1%	Lowered
Aug 6, 2026	total core sales growth	FY2026	+11% – +14%	Raised
May 7, 2026	core organic sales growth	FY2026	+2% – +4%	New
May 7, 2026	core adjusted EBITDA	FY2026	$575.00M – $595.00M	Reaffirmed
May 7, 2026	core adjusted EPS	FY2026	$5.70 – $5.90	Reaffirmed
May 7, 2026	M&A contribution	FY2026	+4%	New
May 7, 2026	FX impact	FY2026	0% – +1%	Lowered
May 7, 2026	total core sales growth	FY2026	+6% – +9%	New
Feb 20, 2026	core adjusted EBITDA	FY2026	$575.00M – $595.00M	New
Feb 20, 2026	core adjusted EPS	FY2026	$5.70 – $5.90	New
Feb 20, 2026	total core sales growth	FY2026	+6% – +9%	New
Feb 2, 2026	Core aEBITDA	FY2026	$575.00M – $595.00M	New
Feb 2, 2026	Core aEPS	FY2026	$5.70 – $5.90	New
Feb 2, 2026	Core revenue	FY2026	$2.85B – $2.95B	New
Oct 29, 2025	core adjusted EBITDA	FY2025	$535.00M – $540.00M	New
Oct 29, 2025	core adjusted EPS	FY2025	$5.20 – $5.30	New
Oct 29, 2025	total core sales growth	FY2025	+4.5% – +5.5%	New
Oct 29, 2025	core organic sales growth	FY2025	+1%	Lowered
Aug 6, 2025	core adjusted EBITDA	FY2025	$525.00M – $535.00M	Raised
Aug 6, 2025	core adjusted EPS	FY2025	$5.15 – $5.30	Raised
Aug 6, 2025	total core sales growth	FY2025	+1.5% – +3.5%	Raised
Aug 6, 2025	core organic sales growth	FY2025	0% – +2%	Lowered
May 1, 2025	core adjusted EBITDA	FY2025	$520.00M – $530.00M	Raised
May 1, 2025	core adjusted EPS	FY2025	$5.10 – $5.25	Reaffirmed
May 1, 2025	M&A	FY2025	+2% – +2.5%	Raised
May 1, 2025	FX	FY2025	-3%	Lowered
May 1, 2025	total core sales growth	FY2025	-1% – +1.5%	Raised
May 1, 2025	core organic sales growth	FY2025	0% – +2%	Raised
Feb 20, 2025	core adjusted EBITDA	FY2025	$515.00M – $530.00M	New
Feb 20, 2025	core adjusted EPS	FY2025	$5.10 – $5.25	New
Feb 20, 2025	core organic growth	FY2025	0% – +2%	New
Feb 20, 2025	total core sales growth	FY2025	-2% – 0%	New
Oct 29, 2024	core organic sales growth	FY2024	0% – +1%	New
Oct 29, 2024	core adjusted EBITDA	FY2024	$500.00M – $515.00M	Raised
Oct 29, 2024	core adjusted EPS	FY2024	$4.80 – $4.95	Raised
Oct 29, 2024	M&A	FY2024	+1%	Lowered
Oct 29, 2024	FX	FY2024	-2.5%	Lowered
Oct 29, 2024	total core sales growth	FY2024	-1.5% – -0.5%	Raised
Aug 2, 2024	core adjusted EBITDA	FY2024	$495.00M – $515.00M	Lowered
Aug 2, 2024	core adjusted EPS	FY2024	$4.75 – $4.95	Reaffirmed
Aug 2, 2024	total core sales growth	FY2024	-2.5% – -0.5%	Lowered
May 1, 2024	core adjusted EBITDA	FY2024	$500.00M – $520.00M	Raised
May 1, 2024	core adjusted EPS	FY2024	$4.75 – $4.95	Raised
May 1, 2024	core organic sales growth	FY2024	+2.5% – +4.5%	Reaffirmed
May 1, 2024	total core sales growth	FY2024	+1.5% – +3.5%	Reaffirmed
Feb 29, 2024	core adjusted EBITDA	FY2024	$495.00M – $515.00M	New
Feb 29, 2024	core adjusted EPS	FY2024	$4.65 – $4.85	New
Feb 29, 2024	core organic growth	FY2024	+2.5% – +4.5%	New
Feb 29, 2024	total core sales growth	FY2024	+1.5% – +3.5%	New
Nov 1, 2023	core adjusted EBITDA	FY2023	$465.00M – $475.00M	Raised
Nov 1, 2023	core adjusted EPS	FY2023	$4.30 – $4.40	Raised
Nov 1, 2023	core organic sales growth	FY2023	+5% – +6%	Raised
Nov 1, 2023	total core sales growth	FY2023	+6.5% – +7.5%	Raised
Aug 1, 2023	core adjusted EBITDA	FY2023	$450.00M – $465.00M	Raised
Aug 1, 2023	core adjusted EPS	FY2023	$4.10 – $4.30	Raised
Aug 1, 2023	core organic sales growth	FY2023	+4% – +5.5%	Raised
Aug 1, 2023	total core sales growth	FY2023	+6% – +7.5%	Raised
May 2, 2023	core organic sales growth	FY2023	+3.5% – +5.5%	New
May 2, 2023	core adjusted EBITDA	FY2023	$430.00M – $450.00M	Raised
May 2, 2023	core adjusted EPS	FY2023	$3.85 – $4.05	Raised
May 2, 2023	total core sales growth	FY2023	+4% – +6%	Raised
Mar 7, 2023	core adjusted EBITDA	FY2023	$420.00M – $440.00M	New
Mar 7, 2023	core adjusted EPS	FY2023	$3.80 – $4.00	New
Mar 7, 2023	cash conversion	FY2023	90%	New
Mar 7, 2023	core organic growth	FY2023	+3% – +5%	New
Mar 7, 2023	total core sales growth	FY2023	+2% – +4%	New
Nov 3, 2022	core adjusted EBITDA	FY2022	$405.00M – $415.00M	Narrowed
Nov 3, 2022	core adjusted EPS	FY2022	$4.00 – $4.10	Raised
Nov 3, 2022	core organic growth	FY2022	+11% – +14%	New
Nov 3, 2022	total core sales growth	FY2022	+5% – +7%	Raised
Aug 9, 2022	adjusted EBITDA	FY2022	$400.00M – $420.00M	Reaffirmed
Aug 9, 2022	adjusted EPS	FY2022	$3.85 – $4.05	Reaffirmed
Aug 9, 2022	free cash flow	FY2022	$210.00M	Reaffirmed
Aug 9, 2022	sales	FY2022	$2.45B – $2.50B	New
Aug 9, 2022	total reported sales growth	FY2022	+2% – +4%	New
May 10, 2022	adjusted EBITDA	FY2022	$400.00M – $420.00M	New
May 10, 2022	adjusted EPS	FY2022	$3.85 – $4.05	New
May 10, 2022	free cash flow	FY2022	$210.00M	New
May 10, 2022	organic growth	FY2022	+4% – +7%	New
May 10, 2022	sales	FY2022	$2.45B – $2.50B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.